Eli Casdin

Insider Reports History

Entity
Individual
Location
1350 Avenue Of The Americas, Suite 1140, New York, New York
Signature
/s/ Eli Casdin by Agnieszka Gallagher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eli Casdin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 46.7 M $95.8 M $2.05 Jun 28, 2024 Casdin Partners Master Fund, L.P
GeneDx Holdings Corp. Director, 10%+ Owner Class A Common Stock 3.09 M $87.6 M $28.31 Jun 20, 2024 See Casdin Partners Master Fund, LP
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 13.9 M $28.6 M $2.05 Jun 28, 2024 Casdin Private Growth Equity Fund II, L.P.
Tenaya Therapeutics, Inc. Director Common Stock 6.08 M $25.9 M $4.26 Nov 17, 2022 Indirect
GeneDx Holdings Corp. Director, 10%+ Owner Class A Common Stock 433 K $12.3 M $28.31 Jun 20, 2024 See Casdin Partners F01-MSV, LP
GeneDx Holdings Corp. Director, 10%+ Owner Class A Common Stock 333 K $9.43 M $28.31 Jun 20, 2024 See CMLS Holdings LLC
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 2.75 M $5.64 M $2.05 Jun 28, 2024 Direct
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 2.74 M $5.63 M $2.05 Jun 28, 2024 By Casdin Private Growth Equity Fund, L.P.
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 545 K $1.12 M $2.05 Jun 28, 2024 Casdin Amplify Fund, LP
GeneDx Holdings Corp. Director, 10%+ Owner Restricted Stock Unit 12.9 K $366 K $28.31 Jun 26, 2024 Direct
STANDARD BIOTOOLS INC. Director, 10%+ Owner Stock Option (Right to buy) 72.2 K $270 K $3.74 Jun 28, 2024 Direct
GeneDx Holdings Corp. Director, 10%+ Owner Class A Common Stock 7.59 K $215 K $28.31 Jun 20, 2024 Direct
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 18.9 K $38.7 K $2.05 Jun 28, 2024 Indirect
STANDARD BIOTOOLS INC. Director, 10%+ Owner Warrant to purchase common stock (Right to buy) 4.82 M Jan 5, 2024 CMLS Holdings LLC
Tenaya Therapeutics, Inc. Director Warrant 1.35 M Nov 17, 2022 Indirect
Tenaya Therapeutics, Inc. Director Stock Option (Right to buy) 39.7 K Jun 10, 2022 Direct
Absci Corp Director Stock Option (right to buy) 28.7 K Jun 8, 2022 Direct
Century Therapeutics, Inc. Director Stock Option (right to buy) 19.9 K Jun 9, 2022 Direct
GeneDx Holdings Corp. Director, 10%+ Owner Stock Option (Right to Buy) 8.82 K Jul 21, 2023 Direct
EQRx, Inc. 10%+ Owner Common Stock 0 $2.21 Nov 9, 2023 Indirect
EQRx, Inc. 10%+ Owner Earn-out Shares 0 Nov 9, 2023 Indirect
EQRx, Inc. 10%+ Owner Stock Option (Right to Buy) 0 Nov 9, 2023 Direct
EQRx, Inc. 10%+ Owner Warrants to purchase Class A Common Stock (right to buy) 0 Nov 9, 2023 Indirect
SomaLogic, Inc. Director, 10%+ Owner Common Stock 0 $2.43 Jan 5, 2024 By Casdin Master Fund, L.P.
SomaLogic, Inc. Director, 10%+ Owner Common Stock 0 $2.43 Jan 5, 2024 By Casdin Private Growth Equity Fund, L.P.
SomaLogic, Inc. Director, 10%+ Owner Common Stock 0 $2.43 Jan 5, 2024 By CMLS Holdings II LLC
SomaLogic, Inc. Director, 10%+ Owner Common Stock 0 $2.43 Jan 5, 2024 Direct
SomaLogic, Inc. Director, 10%+ Owner Restricted Stock Unit 0 $2.43 Jan 5, 2024 Direct
SomaLogic, Inc. Director, 10%+ Owner Stock Option (Right to buy) 0 Jan 5, 2024 Direct
SomaLogic, Inc. Director, 10%+ Owner Warrant to purchase common stock (Right to buy) 0 Jan 5, 2024 By CMLS Holdings II LLC

Insider Reports Filed by Eli Casdin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LAB STANDARD BIOTOOLS INC. Jun 28, 2024 2 $0 4 Jul 2, 2024 Director, 10%+ Owner
WGS GeneDx Holdings Corp. Jun 26, 2024 1 $0 4 Jun 27, 2024 Director, 10%+ Owner
WGS GeneDx Holdings Corp. Jun 20, 2024 2 $0 4 Jun 24, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Feb 20, 2024 1 $57 K 4 Feb 22, 2024 Director, 10%+ Owner
SLGC SomaLogic, Inc. Jan 5, 2024 10 $0 4 Jan 9, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Jan 5, 2024 10 $0 4 Jan 9, 2024 Director, 10%+ Owner
EQRX EQRx, Inc. Nov 9, 2023 9 $0 4 Nov 14, 2023 10%+ Owner
WGS GeneDx Holdings Corp. Jul 21, 2023 2 $0 4 Jul 25, 2023 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
LAB STANDARD BIOTOOLS INC. May 17, 2023 3 $2.63 M 4 May 19, 2023 Director, 10%+ Owner
WGS GeneDx Holdings Corp. May 2, 2023 2 $0 4 May 4, 2023 Director
SLGC SomaLogic, Inc. Mar 17, 2023 2 $0 4 Mar 22, 2023 Director
WGS GeneDx Holdings Corp. Jan 31, 2023 2 $30 M 4 Feb 2, 2023 Director, 10%+ Owner
EQRX EQRx, Inc. Jan 1, 2023 3 $0 4 Jan 4, 2023 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Nov 17, 2022 2 $10 M 4 Nov 25, 2022 Director
EQRX EQRx, Inc. Sep 30, 2022 1 $0 4 Oct 4, 2022 Director, 10%+ Owner
SLGC SomaLogic, Inc. Sep 29, 2022 1 $0 4 Dec 14, 2022 Director
LAB STANDARD BIOTOOLS INC. Jun 15, 2022 2 $79.2 K 4 Jun 17, 2022 Director
TNYA Tenaya Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
IPSC Century Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
ABSI Absci Corp Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
WGSWW Sema4 Holdings Corp. May 2, 2022 1 $0 4/A May 6, 2022 Director
WGSWW Sema4 Holdings Corp. Apr 29, 2022 1 $45.8 M 4 May 3, 2022 Director
WGSWW Sema4 Holdings Corp. Apr 27, 2022 2 $0 4 May 12, 2022 Director
LAB STANDARD BIOTOOLS INC. Apr 4, 2022 3 $0 4 Apr 6, 2022 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Apr 4, 2022 0 $0 3 Apr 6, 2022 Director
SLGC SomaLogic, Inc. Mar 1, 2022 2 $0 4 Mar 3, 2022 Director
EQRX EQRx, Inc. Dec 17, 2021 13 $50 M 4/A Dec 23, 2021 Director, 10%+ Owner
SLGC SomaLogic, Inc. Oct 27, 2021 1 $0 4 Dec 13, 2021 Director
WGSWW Sema4 Holdings Corp. Oct 15, 2021 2 $0 4 Oct 19, 2021 Director
SLGC SomaLogic, Inc. Sep 1, 2021 5 $25 M 4 Sep 3, 2021 Director
TNYA Tenaya Therapeutics, Inc. Aug 3, 2021 6 $12.8 M 4 Aug 4, 2021 Director, 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director, 10%+ Owner
ABSI Absci Corp Jul 26, 2021 7 -$538 K 4 Jul 28, 2021 Director
WGSWW Sema4 Holdings Corp. Jul 22, 2021 4 $0 4 Jul 27, 2021 Director
ABSI Absci Corp Jul 21, 2021 0 $0 3 Jul 21, 2021 Director, 10%+ Owner
IPSC Century Therapeutics, Inc. Jun 22, 2021 3 $15 M 4 Jun 22, 2021 Director
IPSC Century Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
IPSC Century Therapeutics, Inc. Jun 17, 2021 0 $0 3 Jun 17, 2021 Director